Skip to main content
. 2020 Nov 18;23(1):86–98. doi: 10.1007/s12017-020-08629-9

Fig. 3.

Fig. 3

PPAR-β/δ engagement in neurological disorders. AD-Alzheimer’s disease, PD Parkinson’s disease, HD Huntington’s disease, MS multiplex sclerosis, ALS amyotrophic lateral sclerosis